Correlation Between Eupraxia Pharmaceuticals and Opus Genetics,
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals Common and Opus Genetics,, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Opus Genetics,.
Diversification Opportunities for Eupraxia Pharmaceuticals and Opus Genetics,
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eupraxia and Opus is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals Commo and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals Common are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Opus Genetics, go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and Opus Genetics,
Given the investment horizon of 90 days Eupraxia Pharmaceuticals Common is expected to under-perform the Opus Genetics,. But the pink sheet apears to be less risky and, when comparing its historical volatility, Eupraxia Pharmaceuticals Common is 1.37 times less risky than Opus Genetics,. The pink sheet trades about -0.04 of its potential returns per unit of risk. The Opus Genetics, is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 117.00 in Opus Genetics, on November 2, 2024 and sell it today you would lose (9.00) from holding Opus Genetics, or give up 7.69% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 98.33% |
| Values | Daily Returns |
Eupraxia Pharmaceuticals Commo vs. Opus Genetics,
Performance |
| Timeline |
| Eupraxia Pharmaceuticals |
| Opus Genetics, |
Eupraxia Pharmaceuticals and Opus Genetics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eupraxia Pharmaceuticals and Opus Genetics,
The main advantage of trading using opposite Eupraxia Pharmaceuticals and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.| Eupraxia Pharmaceuticals vs. Westrock Coffee | Eupraxia Pharmaceuticals vs. Keurig Dr Pepper | Eupraxia Pharmaceuticals vs. Udemy Inc | Eupraxia Pharmaceuticals vs. Elite Education Group |
| Opus Genetics, vs. 51Talk Online Education | Opus Genetics, vs. Clear Channel Outdoor | Opus Genetics, vs. National CineMedia | Opus Genetics, vs. Integral Ad Science |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |